A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures
- 17 March 1998
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 30 (1) , 31-40
- https://doi.org/10.1016/s0920-1211(97)00082-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tiagabine Therapy for Complex Partial SeizuresArchives of Neurology, 1997
- Tiagabine in the Management of EpilepsyEpilepsia, 1997
- Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugsEpilepsy Research, 1995
- Pharmacokinetics of Tiagabine, a γ‐Aminobutyric Acid‐Uptake Inhibitor, in Healthy Subjects After Single and Multiple DosesEpilepsia, 1995
- Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trialEpilepsy Research, 1995
- Evaluation of Antiepileptic Drug EfficacyDrugs, 1994
- High-performance liquid chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitorEuropean Journal of Pharmacology, 1991
- Anatomy, physiology, and pathology of epilepsyThe Lancet, 1990
- (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake CarrierJournal of Neurochemistry, 1990